Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Polycystic Ovary Syndrome 21Insulin Resistance 5Obesity 4Neoplasms 3Prostatic Neoplasms 2Motor Activity 2Menstruation Disturbances 2Medulloblastoma 2Infertility 2Diabetes Mellitus 2Breast Neoplasms 2Weight Loss 1Vitamin D Deficiency 1Triple Negative Breast Neoplasms 1Toxemia 1Thyroid Neoplasms 1Premature Birth 1Pregnancy Complications 1Prediabetic State 1Pre-Eclampsia 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Non-DM Stage II High-risk Colorectal Cancer 1Neoplasm Metastasis 1Mouth Neoplasms 1Metabolic Syndrome 1Liver Neoplasms 1Infertility, Female 1Hyperinsulinism 1Hyperandrogenism 1

Interventions

pembrolizumab 2Specimen Handling 2Early Intervention, Educational 2pertuzumab 1X-Ray Therapy 1Watchful Waiting 1Trastuzumab 1Taxes 1Surgical Procedures, Operative 1Standard of Care 1Protons 1Proton Therapy 1Practice Guidelines as Topic 1Paclitaxel 1Observation 1Motivational Interviewing 1Methods 1Metformin 1Magnetic Resonance Spectroscopy 1High-Energy Shock Waves 1Educational Status 1Doxorubicin 1Docetaxel 1Cyclophosphamide 1Carboplatin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Anatomic Stage I Breast Cancer AJCC v8 × Metformin × Clear all
NCT06763328 2026-01-22

Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy

City of Hope Medical Center

Phase 3 Recruiting
200 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡